Trials / Completed
CompletedNCT05625217
Total-Body FDG PET for Radiotherapy Response Assessment in Head and Neck Cancer
Characterizing Dynamics of FDG Uptake With Total-Body PET for Response Assessment in Radiotherapy for Head and Neck Cancer
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 7 (actual)
- Sponsor
- University of California, Davis · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The overall goal of this research study is to understand how 18F-fluorodeoxyglucose (FDG), a radioactive sugar behaves in head and neck cancer (HNC) and inflammation immediately following injection and at many hours post-injection, with the world's first total-body positron emission tomography (PET)/computed tomography (CT) scanner (EXPLORER).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Total Body PET/CT Imagin | Total-body PET imaging at different timepoints |
Timeline
- Start date
- 2023-02-27
- Primary completion
- 2024-11-20
- Completion
- 2024-11-20
- First posted
- 2022-11-22
- Last updated
- 2026-03-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05625217. Inclusion in this directory is not an endorsement.